[1]薛瑶 乔子梅.高迁移率蛋白B1基因单核苷酸多态性对动脉瘤性蛛网膜下腔出血后迟发性脑缺血的影响[J].卒中与神经疾病杂志,2019,26(03):294-297302.[doi:10.3969/j.issn.1007-0478.2019.03.009]
　Xue Yao,Qiao Zimei.The effects of single nucleotide polymorphism of high-mobility group box-1 protein on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage[J].Stroke and Nervous Diseases,2019,26(03):294-297302.[doi:10.3969/j.issn.1007-0478.2019.03.009]
点击复制

高迁移率蛋白B1基因单核苷酸多态性对动脉瘤性蛛网膜下腔出血后迟发性脑缺血的影响()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第26卷
期数:
2019年03期
页码:
294-297302
栏目:
论 著
出版日期:
2019-06-25

文章信息/Info

Title:
The effects of single nucleotide polymorphism of high-mobility group box-1 protein on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
文章编号:
1007-0478(2019)03-0294-05
作者:
薛瑶 乔子梅
719000 陕西省榆林市第一医院神经内科[薛瑶 乔子梅(通信作者)]
Author(s):
Xue Yao;  Qiao Zimei
Department of Neurology, Yulin First Hospital, Yulin Shanxi 719000
关键词:
动脉瘤性蛛网膜下腔出血 迟发性脑缺血 高迁移率蛋白B1 单核苷酸多态性
Keywords:
Aneurysmal subarachnoid hemorrhage Delayed cerebral ischemia High-mobility group box-1 Single nucleotide polymorphism
分类号:
R743.35
DOI:
10.3969/j.issn.1007-0478.2019.03.009
文献标志码:
A
摘要:
目的 探讨高迁移率蛋白B1(high-mobility group box-1 protein,HMGB1)的单核苷酸多态性(single nucleotide polymorphism,SNP)在预测动脉瘤性蛛网膜下腔出血(aneurysmal subarachnoid hemorrhage,aSAH)后迟发性脑缺血(delayed cerebral ischemia,DCI)发生的价值。方法 纳入2012年1月-2015年12月本院收治的149例aSAH患者,并以50例体检健康人群为对照组,通过外周血检测HMGB1的rs2249825(3814C/G)的基因型,并通过多因素logistics回归分析确定HMGB1的rs2249825基因型与DCI发生的关系。结果 149例aSAH患者和50例健康对照组人群的HMGB1 SNP rs2249825基因型均处于哈迪温伯格平衡状态,但2组的HMGB1的rs2249825基因型频率无统计学差异(χ2=4.091,P=0.129)。149例aSAH患者中有31例(20.8%)发生DCI,与无DCI发生的aSAH患者比较,发生DCI患者的Hunt-Hess分级≥3级(45.2% vs 16.0%,P=0.001)、脑水肿(32.3% vs 10.2%,P=0.002)、脑血管痉挛(61.3% vs 12.7%,P<0.001)、出院时mRS评分≥3分(74.2% vs 46.6%,P=0.006)、出院后90 d mRS评分≥3分(61.3% vs 32.2%,P=0.003)和HMGB1的rs2249825基因型CG或GG患者(54.8% vs 19.5%,P<0.001)比例更高。多因素logistics回归分析确定HMGB1的rs2249825基因型为CG或GG(OR=5.695,95% CI=1.804～17.975,P=0.003)、Hunt-Hess分级≥3级(OR=1.805,95% CI=1.132～2.880,P=0.013)和脑水肿(OR=2.195,95% CI=1.321～3.915,P=0.005)是影响aSAH患者发生DCI的独立危险因素。结论 HMGB1的rs2249825的次要等位基因G与aSAH患者DCI发生风险增加有关。
Abstract:
ObjectiveTo investigate the value of single nucleotide polymorphism(SNP)of high-mobility group box-1 protein(HMGB1)in predicting the delayed cerebral ischemia(DCI)occurrence after aneurysmal subarachnoid hemorrhage(aSAH).Methods 149 patients with aSAH admitted to our hospital were enrolled from January 2012 to December 2015, and 50 healthy subjects were selected as the control group. The genotype of HMGB1 rs2249825(3814C/G)was detected in peripheral blood sample. Multivariate logistic regression analysis was used to determine the association of HMGB1 rs2249825 genotype with DCI.Results The HMGB1 rs2249825 genotypes in 149 patients with aSAH and 50 healthy controls were in Hardy-Weinberg equilibrium, but there was no significant difference in the frequency of HMGB1 rs2249825 genotypes between the two groups(χ2=4.091, P=0.129). DCI occurred in 31 of 149 patients with aSAH(20.8%). Compared with aSAH patients without DCI, the Hunt-Hess grade ≥3(45.2% vs 16.0%, P=0.001), cerebral edema(32.3% vs 10.2%, P=0.002), cerebral vasospasm(61.3% vs 12.7%, P<0.001), mRS score ≥3 at discharge(74.2% vs 46.6%, P=0.006), mRS score ≥3 at 90-day post-discharge(61.3% vs 32.2%, P=0.003)and the HMGB1 rs2249825genotypes of CG or GG(54.8% vs 19.5%, P<0.001)were significantly higher in aSAH patients with DCI. Multivariate logistic regression analysis confirmed that HMGB1 rs2249825 genotype with CG or GG(OR=5.695, 95% CI=1.804～17.975, P=0.003), Hunt-Hess grade≥3(OR=1.805, 95% CI=1.132～2.880, P=0.013)and cerebral edema(OR=2.195, 95% CI=1.321～3.915, P=0.005)were independent risk factors for DCI occurance in aSAH patients.Conclusion The secondary allele G of HMGB1rs2249825 was associated with an increased risk of DCI in patients with aSAH.

参考文献/References:

[1] Sehba FA, Hou J, Pluta RM, et al. The importance of early brain injury after subarachnoid hemorrhage[J]. Progress in Neurobiology, 2012, 97(1):14-37.
[2] Hendrix P, Foreman PM, Harrigan MR, et al. Impact of high-mobility group box-1 polymorphism on delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage[J]. World Neurosurg, 2017, 101:325-330.
[3] 江澈,张磊,黄清海,等.动脉瘤性蛛网膜下腔出血患者急性期外周血中高迁移率族蛋白1水平的变化[J].中国脑血管病杂志,2013,10(2):89-91.
[4] 孙丰兵,李世亭,万亮.高迁移率族蛋白B1与自发性蛛网膜下腔出血相关性的研究进展[J].国际神经病学神经外科学杂志,2015,42(1):59-62.
[5] 国家卫生计生委脑卒中防治工程编写委员.中国动脉瘤性蛛网膜下腔出血诊疗指导规范[J].中国脑血管病杂志,2016,13(7):384-392.
[6] Vergouwen MD, Vermeulen M, Van Gijn JA, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies proposal of a multidisciplinary research group[J]. Stroke, 2010, 41(10):2391-2395.
[7] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国蛛网膜下腔出血诊治指南2015[J].中华神经科杂志,2016,49(3):182-191.
[8] Zhang Ding-ding, Wu Wei, Yan Hui-ying, et al. Upregulation of HMGB1 in wall of ruptured and unruptured human cerebral aneurysms:preliminary results[J]. Neurological Sciences, 2016, 37(2):219-226.
[9] Venereau E, De Leo F, Mezzapelle RA, et al. HMGB1 as biomarker and drug target[J]. Pharmacological Research, 2016, 111:534-544.
[10] Sun Qing, Wu Wei, Hu Yang-chun, et al. Early release of high-mobility group box 1(HMGB1)from neurons in experimental subarachnoid hemorrhage in vivo and in vitro[J]. Journal of Neuroinflammation, 2014, 11:106.
[11] Chen Yan, Li Guang-ping, Liu Yan-xia, et al. Translocation of endogenous danger signal HMGB1 from nucleus to membrane microvesicles in macrophages[J]. Journal of Cellular Physiology, 2016, 231(11):2319-2326.
[12] Pedrazzi M, Patrone M, Passalacqua M, et al. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling[J]. Journal of Immunology, 2007, 179(12):8525-8532.
[13] Zhu Xiang-dong, Chen Jing-sen, Zhou Feng, et al. Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage[J]. Journal of Neuroinflammation, 2012, 9(1):194.
[14] Nakahara T, Tsuruta R, Kaneko T, et al. High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage[J]. Neurocritical Care, 2009, 11(3):362-368.
[15] King MD, Laird MD, Ramesh SS, et al. Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage:an emerging role for neuroproteomics[J]. Neurosurgical Focus, 2010, 28(1):E10.
[16] 闫聪,刘耀(综述),高成(审校).蛛网膜下腔出血后迟发性脑缺血研究进展[J].检验医学与临床,2015,12(16):2470-2473.
[17] Zhao Xu-dong, Mao Hai-yan, Lv Jing, et al. Expression of high-mobility group box-1(HMGB1)in the basilar artery after experimental subarachnoid hemorrhage[J]. Journal of Clinical Neuroscience, 2016, 27:161-165.
[18] Chayka O, Kintscher J, Braas D, et al. v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter[J]. Molecular and Cellular Biology, 2005, 25(1):499-511.

更新日期/Last Update: 2019-06-25